Thyrocare Technologies Ltd
Company Profile
Business description
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
Contact
D-37/3, TTC Industrial Area
MIDC, Turbhe
Opposite Sandoz
Navi MumbaiMH400703
INDT: +91 2230903000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
1,948
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,826.70 | 48.80 | 0.56% |
CAC 40 | 7,901.35 | 22.89 | 0.29% |
DAX 40 | 24,533.74 | 15.82 | -0.06% |
Dow JONES (US) | 44,458.30 | 217.54 | 0.49% |
FTSE 100 | 8,956.49 | 89.47 | 1.01% |
HKSE | 24,028.37 | 136.05 | 0.57% |
NASDAQ | 20,611.34 | 192.87 | 0.94% |
Nikkei 225 | 39,646.36 | 174.92 | -0.44% |
NZX 50 Index | 12,760.20 | 8.41 | -0.07% |
S&P 500 | 6,263.26 | 37.74 | 0.61% |
S&P/ASX 200 | 8,589.20 | 50.60 | 0.59% |
SSE Composite Index | 3,509.68 | 16.63 | 0.48% |